跳至主要内容
临床试验/NCT00432549
NCT00432549Unknown4 期

Evaluation of Almotriptan and Topiramate in the Detoxification and Treatment of Subjects With Medication Overuse Headache

The New England Center for Headache, P.C.2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2007年1月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
发起方
入组人数
60
试验地点
2
主要终点
Pain free days through day ninety

研究概览

简要总结

The purpose of this study is to assess the benefits of almotriptan used as a transitional therapy and topiramate in subjects with medication overuse headaches (MOH.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Medication overuse headaches 18 years of age and older Must have a diagnosis of probable medication overuse headache Must have greater than fifteen headache days per month Must be in generally good health Female subjects must be postmenopausal or practicing an acceptable method of birth control

排除标准

  • Not overusing six or more tablets per day of compounds containing barbituates opioids No overuse of triptans Previous failure or side effects with topiramate or almotriptan Cannot be pregnant or lactating

结局指标

主要结局

Pain free days through day ninety

Primary for the prevention of relapse

Number of days with mild or no pain in the first two weeks of treatment

Primary measure for the detoxification period

次要结局

  • Primary measure for the detoxification period
  • Number of days without any headache in the first two weeks of treatment
  • Primary for the prevention of relapse
  • Headache frequency through day ninety

研究者

发起方
The New England Center for Headache, P.C.
申办方类型
Other

研究点 (2)

Loading locations...

相似试验